Hint mode is switched on Switch off
For swift navigation between sections

Idorsia
LEI 506700XOVZUB107S5720

PDF download

Choose all Reset all
Download Cancel
Organization name
Idorsia Ltd
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
743 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Idorsia is an independent biopharmaceutical company based on science and innovation. The company is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia was incorporated in March 2017 and listed on the SIX Swiss Exchange.

Awards

News

13/01/2025 Idorsia Seeks Bondholder Approval to Extend Debt Maturity
All organization news

Documentation

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    506700XOVZUB107S5720
  • NACE
    *** ***
  • NAICS
    *** ***
  • UID
    CHE340129854
Registration is required to get access.